← Back
$REGN All transactions

REGENERON PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$29K

Shares

37

Price

$783

Filed

Feb 11

Insider

Name

Pitofsky Jason

Title

SVP Controller

CIK

0002009236

Roles

Officer

Transaction Details

Transaction Date

2026-02-09

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,470

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025. | Represents volume-weighted average price of sales of 521 shares of Company stock on February 9, 2026 at prices ranging from $776.05 to $776.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. | Represents volume-weighted average price of sales of 391 shares of Company stock on February 9, 2026 at prices ranging from $777.33 to $777.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. | Represents volume-weighted average price of sales of 563 shares of Company stock on February 9, 2026 at prices ranging from $778.00 to $778.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. | Represents volume-weighted average price of sales of 205 shares of Company stock on February 9, 2026 at prices ranging from $779.19 to $779.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. | Represents volume-weighted average price of sales of 75 shares of Company stock on February 9, 2026 at prices ranging from $780.03 to $780.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. | Represents volume-weighted average price of sales of 26 shares of Company stock on February 9, 2026 at prices ranging from $781.18 to $781.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. | Represents volume-weighted average price of sales of 37 shares of Company stock on February 9, 2026 at prices ranging from $782.22 to $782.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. | Represents volume-weighted average price of sales of 144 shares of Company stock on February 9, 2026 at prices ranging from $783.17 to $783.29. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. | Represents volume-weighted average price of sales of 53 shares of Company stock on February 9, 2026 at prices ranging from $785.72 to $785.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. | The stock option award vested in four equal annual installments, commencing one year after the date of grant.

Filing Info

Accession No.

0002009236-26-000001

Form Type

4

Issuer CIK

0000872589

Pitofsky Jason's History

Date Ticker Type Value
2026-02-09 REGN M $492K
2026-02-09 REGN $16K
2026-02-09 REGN $405K
2026-02-09 REGN $304K
2026-02-09 REGN $438K
2026-02-09 REGN $160K
2026-02-09 REGN $59K
2026-02-09 REGN $20K
2026-02-09 REGN $29K
2026-02-09 REGN $113K

Other Insiders at REGN (90d)

Insider Bought Sold Last
RYAN ARTHUR F $234K 2026-04-01
Zoghbi Huda Y $1.3M 2026-02-19
Pitofsky Jason
SVP Controller
$1.6M 2026-02-09